This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: University of Maastricht. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Anke Sambeth: Innovator in Cognitive Impairment Treatment
Introduction
Anke Sambeth is a notable inventor based in Holtum, Netherlands. She has made significant contributions to the field of cognitive health, particularly in the treatment of cognitive impairments. Her innovative approach focuses on utilizing a specific class of medication to address various cognitive challenges.
Latest Patents
Anke Sambeth holds a patent for her invention titled "Treatment of cognitive impairment with PDE4 inhibitor." This invention relates to the treatment of varying degrees of cognitive impairment associated with conditions such as aging, Alzheimer's disease, and schizophrenia. The method involves low-dose administration of a PDE4 inhibitor, specifically roflumilast, which has shown promise in improving cognitive function.
Career Highlights
Anke Sambeth is affiliated with Maastricht University, where she conducts her research and development work. Her academic background and research focus have positioned her as a key figure in the exploration of cognitive health solutions.
Collaborations
Anke has collaborated with esteemed colleagues such as Jos Prickaerts and Marlies Van Duinen. These partnerships have enhanced her research efforts and contributed to the advancement of her innovative treatments.
Conclusion
Anke Sambeth's work in the treatment of cognitive impairment showcases her dedication to improving mental health through innovative solutions. Her patent and collaborations reflect her commitment to advancing the field of cognitive health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile